Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Minoxidil protects heart and improves recovery.

Some blood pressure medications are linked to a higher risk of skin cancer.

Mitoquinone protects heart cells from doxorubicin damage and slightly boosts its effect on prostate cancer cells.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tadalafil and Finasteride may help treat aggressive melanoma.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Minoxidil increases cell layer permeability by reducing tight junction proteins and raising ROS levels.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

LGD1069 effectively prevents breast tumors in mice without toxicity.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

Minoxidil topical foam is a better, less irritating treatment for hair loss.